january 28, 2014 presented by natalie frison,
DESCRIPTION
Head and Neck Cancer with Fibula Free-Flap Surgery and Provision of Immuno -Enhanced Enteral Nutrition Support . January 28, 2014 Presented by Natalie Frison, Sodexo Mid-Atlantic Dietetic Internship, Class of 2014 . Outline . Introduction Discussion of Disease Current Research - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/1.jpg)
Head and Neck Cancer with Fibula Free-Flap Surgery and Provision of Immuno-Enhanced Enteral Nutrition Support
January 28, 2014Presented by Natalie Frison, Sodexo Mid-Atlantic Dietetic Internship, Class of 2014
![Page 2: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/2.jpg)
2
Outline Introduction Discussion of Disease
Current Research Medical Interventions Nutrition Interventions
Patient History Social History Medical History Nutrition History Objective Data
Discussion of Treatment and Hospital Course
![Page 3: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/3.jpg)
3
Learning Objectives 1. Describe the surgical procedure for the
resection of head and neck cancer.2. Name two nutrients commonly
included in immune-enhancing enteral nutrition formulas and explain their functions in post-surgical patients.
![Page 4: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/4.jpg)
4
Introduction S.M. is a 79 yo male Admitting diagnosis: squamous cell
carcinoma of the right retromolar trigone
Admitted to GWUH on 12/2/13 for tumor resection
Discharged to hospice care on 1/1/14 Discharge diagnosis: dermal metastasis
of squamous cell carcinoma
![Page 5: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/5.jpg)
5
http://www.cancer.gov/cancertopics/pdq/treatment/lip-and-oral-cavity/Patient/page1/AllPages/Print
![Page 6: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/6.jpg)
6
Discussion of Disease
![Page 7: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/7.jpg)
7
Oral Squamous Cell Carcinoma (SCC) Oral cancer: 6th most common cancer
globally1
SCC accounts for 90% of all oral cancers1,2
Associated with tobacco use, alcohol consumption, and low intake of fruits and vegetables1,2,3
Also may be linked to HPV, genetic markers3
More prevalent in men than in women1,2
Average age at diagnosis: 62 years2
![Page 8: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/8.jpg)
8
Oral Squamous Cell Carcinoma (SCC) Treatment: surgery, radiation,
chemotherapy 5-year survival: about 50%1
About 2/3 of patients present with advanced stage and metastatic growth2
Prognosis associated with TNM stage2,3
![Page 9: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/9.jpg)
9
Oral Squamous Cell Carcinoma (SCC) Prognosis also associated with surgical
margins2,3
Even with “successful” surgery, margins may contain pre-cancerous keratinocytes
Local recurrence: about 30% SCC has high incidence of metastasis:2,3
Lymph node Perineural Vascular
![Page 10: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/10.jpg)
10
Dermal Metastasis Dermal metastasis is rare4
Survival: 1 to 65 weeks4
Considered terminal stage of disease4
Palliative care4
![Page 11: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/11.jpg)
11
Free-Flap Reconstruction Tumor is resected from head/neck Bone, tissue, and vasculature are taken
from a donor site on the patient and transferred to the site of resection
Osteocutaneous free-flap tissue transfer is preferred surgery for mandibular defect reconstruction5
Well-vascularized, thick tissue6
Restore mandible form and function
![Page 12: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/12.jpg)
12
A-B) Before surgery. C-D) 60 days after surgery.7
![Page 13: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/13.jpg)
13
A-B) Frontal and lateral view of the patient after surgery. C-D) 3D-CT 6 months after surgery.7
![Page 14: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/14.jpg)
14
Free-Flap Reconstruction Success rate: 90-99%8,9
Considered safe, effective procedure for elderly patients8,9
5-year survival: 51%5
Return of oral function: 89%5
![Page 15: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/15.jpg)
15
Nutrition in Head & Neck Cancer High risk for malnutrition due to dysphagia10
Obstruction due to tumor Effect of chemo/radiation Result of surgery
Use of enteral nutrition support PEG is preferred route10
Pretreatment/home EN10
Prevent weight loss, dehydration, nutrient deficiencies, treatment interruptions10
![Page 16: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/16.jpg)
16
Immuno-Nutrition Surgery -> inflammatory response ->
immunosuppression -> infections 11,12, 13
Supplementation of nutrients in addition to energy and protein Modulate inflammatory response Boost immune system Decrease risk for infection
![Page 17: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/17.jpg)
17
Immuno-Nutrition Nutrients include:
Arginine Glutamine Omega-3 fatty acids Antioxidants Trace elements
![Page 18: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/18.jpg)
18
Immuno-Nutrition Arginine
Essential component of immune cells, especially lymphocytes (T cells)11,12,13,14
Precursor of cells used for collagen synthesis and tissue repair13,14
Glutamine Increased production of immune cells11,12,14
Improved gut barrier function11,12
Increased protein synthesis12,14
![Page 19: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/19.jpg)
19
Immuno-Nutrition Omega-3 fatty acids
Decreased production of inflammatory mediators11,12,13,14
Antioxidants and trace elements11,14
Zinc, copper, selenium, vitamin E, vitamin C, N-acetyl cysteine
Anti-inflammatory properties Reduce oxidative stress
![Page 20: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/20.jpg)
20
EAL Recommendation Pre-operative and post-operative use of
arginine-containing EN15,16,17,18,19
Not recommended Research shows no significant impact Fair Imperative
![Page 21: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/21.jpg)
21
Immuno-Nutrition: Consensus Sources: ESPEN,11 SCCM,12 A.S.P.E.N.12 Good efficacy in surgical patients11,12,13
Reduction in rate of infections11,12,13
Decreased length of hospital stay11,12,13,14
No significant effect on mortality11,12,13
More benefits seen in malnourished patients13
Should be initiated pre-operatively12
![Page 22: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/22.jpg)
22
Case Study: Oral SCC, Free-flap Reconstruction, and Provision of Immuno-enhancing EN
![Page 23: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/23.jpg)
23
Patient Social History S.M. was a 79 yo male Muslim Retired Widowed Supportive family Speaks English and Urdu Former smoker (risk factor) Does not drink alcohol
![Page 24: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/24.jpg)
24
Medical and Nutrition History PMH: GERD, BPH 10/8/13: Diagnosed at MFA Otolaryngology
clinic Squamous cell carcinoma of the right retromolar
trigone 11/17/13: Presented to ED for jaw pain
Followed by ENT team PEG placement pre-operatively on 11/22 Scheduled tumor resection
11/25/13: Discharged
![Page 25: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/25.jpg)
25
Nutrition History Use of EN at home via PEG
Pivot 1.5 (immuno-enhanced) 1.2 L per day
Usually 400 mL bolus TID Family support No complaints
Food recall: broth, water
![Page 26: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/26.jpg)
26
Pivot 1.5 Cal Sole-source enteral nutrition formula Produced by Abbott Nutrition “Very-high-protein, calorically dense, immune-
supporting, hydrolyzed, peptide-based enteral formula for use in metabolically stressed, immunosuppressed patients, such as those with…head and neck cancer”20
Includes arginine, glutamine, omega-3 fatty acids, vitamin C, vitamin E, zinc, copper, selenium20
![Page 27: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/27.jpg)
27
Patient Data (Admission) Ht = 178 cm (5’10”) Wt = 56.7 kg (125 lb) BMI = 17.9 (underweight) Physical findings: muscle wasting,
appears debilitated
![Page 28: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/28.jpg)
28
Home Medications Percocet analgesic Colace stool softener Tamsulosin BPH treatment Gabapentin anti-epileptic Oxycodone analgesic
![Page 29: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/29.jpg)
29
Hospital Course 12/2: Admitted to GWUH for tumor
resection 12/3: Tumor resection and
reconstruction with fibula free flap and right pectoralis muscle flap and awake tracheotomy Involvement of mandible, extension to
base of skull 12/4: ICU to monitor post-surgery
![Page 30: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/30.jpg)
30
Lab Values (12/4) Na 130 L Cl 95 L Mg 1.5 Phos 4.6 H K 4.6 Glu 138 H H/H 11.1 L/32.2 L
![Page 31: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/31.jpg)
31
Medications (Post-surgery) Clindamycin antibiotic Pantoprazole anti-GERD Electrolyte repletion:
Magnesium sulfate Potassium chloride Potassium phosphate
![Page 32: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/32.jpg)
32
Initial Nutrition Assessment Performed on 12/4 Weight history:
Weight at previous admission (11/22) was 129 lb
Admission weight was 125 lb Weight loss: 4 lb in about one week At previous admission, reported weight of 145
lb about 6 months ago >10% weight loss in 6 months: severe weight
loss
![Page 33: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/33.jpg)
33
Initial Nutrition Assessment Assessment
No N/V, mild constipation Muscle mass wasting, temporal wasting,
edema in abdominal area, severe protein-calorie malnutrition
Calorie needs: 1985 kcal (35 kcal per kg)
Protein needs: 113 g (2 g per kg) Fluid needs: 2000 mL (1 mL per kcal)
![Page 34: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/34.jpg)
34
Initial Nutrition Assessment Diagnoses:
Inadequate intake R/T inability to take nutrition by mouth, secondary to head and neck cancer with composite resection of tumor, AEB dependence on EN support, underweight BMI
Increased nutrient needs R/T catabolic state, oncologic processes, and recent surgery AEB patient with elevated energy, protein, and micronutrient needs and weight loss
![Page 35: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/35.jpg)
35
Initial Nutrition Assessment Intervention:
EN via PEG: Pivot 1.5 via continuous administration with daily goal volume of 1.325L (60mL/hr), water flushes 30mL q4h
1988 kcal, 125 g, 1120 mL free water Monitoring and Evaluation
S/S of tolerance to EN administration
![Page 36: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/36.jpg)
36
Hospital Course 12/5-12/7: ICU, vent management and
flap checks 12/9: Transitioned to bolus feeds
220mL q4h with water flushes 12/11: Nutrition reassessment 12/12: Transitioned back to continuous
feeds due to diarrhea
![Page 37: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/37.jpg)
37
Hospital Course 12/15: Confirmation of pneumonia 12/19:
Transferred to ARU Transitioned to bolus feeds Removal of remaining staples SLP: excellent response to PMV
![Page 38: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/38.jpg)
38
Hospital Course 12/24:
Patient complaint of painful abscess on right cheek; also noted nodule on right cheek
Exploration of surgical wound of the neck for infection Biopsy of nodule to confirm dermal
metastasis of SCC Penrose drain placement
![Page 39: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/39.jpg)
39
Hospital Course 12/26:
Transferred to medical unit Right facial swelling and pain with pitting
edema 12/29:
Evidence of expanding dermal metastasis Family meeting planned
![Page 40: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/40.jpg)
40
Hospital Course 12/30:
Wound exploration and washout Confirmation of dermal metastasis No further interventions possible to control
tumor 12/31:
Family meeting Decision made to transition to palliative care Plans to transfer to inpatient hospice care
![Page 41: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/41.jpg)
41
Hospital Course 1/1/14:
Pain Management: Recommendation for med regimen for pain control
Palliative Care: Patient knows he is at end of life and desires optimal pain control, does not want further treatment
Discharged to inpatient hospice care for pain control with plans to then discharge home with family and nursing support
Continue EN support
![Page 42: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/42.jpg)
42
References 1. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades:
epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med [serial online]. 2010;39:299-305. Available from: PubMed. Accessed January 18, 2014.
2. Feller L, Lemmer J. Oral squamous cell carcinoma: epidemiology, clinical presentation and treatment. Journal of Cancer Therapy [serial online]. 2012;4:263-268, Available from: Scirp.org. Accessed January 18, 2014.
3. Jadhav KB, Gupta N. Clinicopathological prognostic implicators of oral squamous cell carcinoma: need to understand and revise. N Am J Med Sci [serial online]. 2013;5(12):671-679. Available from: PubMed. Accessed January 19, 2014.
4. Sesterhenn AM, Albers MB, Timmesfeld N, Werner JA, Wiegand S. Dermal metastasis in squamous cell carcinoma of the head and neck. Head Neck [serial online]. 2013;35(6):767-771. Available from: PubMed. Accessed January 19, 2014.
5. Dean NR, Wax MK, Virgin FW, Magnuson JS, Carroll WR, Rosenthal EL. Free flap reconstruction of lateral mandibular defects: indications and outcomes. Otolaryngol Head Neck Surg [serial online]. 2012;146(4):547-552. Available from: PubMed. Accessed January 17, 2014.
![Page 43: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/43.jpg)
43
References 6. Hill JL, Rinker B. Microsurgical reconstruction of large, locally advanced
cutaneous malignancy of the head and neck. Hindawi Publishing Corporation: Internal Journal of Surgical Oncology. Available at: http://www.hindawi.com/journals/ijso/2011/415219/cta/. Accessed January 17, 2014.
7. Pellini R, Mercante G, Spriano G. Step-by-step mandibular reconstruction with free flap fibula modeling. Acta OtorhinolaryngologicaI Italica [serial online]. 2012;32:405-409. Available from: PubMed. Accessed January 19, 2014.
8. Turra F, La Padula S, Razzano S, et al. Microvascular free-flap transfer for head and neck reconstruction in elderly patients. BMC Surgery [serial online]. 2013;13(Suppl 2):S27. Available from: BioMed Central. Accessed January 17, 2014.
9. Tarsitano A, Pizzigallo A, Sgarzani R, Oranges CM, Cipriani R, Marchetti C. Head and neck cancer in elderly patients: is microsurgical free-tissue transfer a safe procedure? Acta Otorhinolaryngologica Italica [serial online]. 2012;32:371-375. Available from: PubMed. Accesssed January 18, 2014.
10. Raykher A, Russo L, Schattner M, Schwartz L, Scott B, Shike M. Enteral nutrition support of head and neck cancer patients. Nutr Clin Pract [serial online]. 2007;22:68. Available from: Sage Journals. Accessed January 15, 2014.
![Page 44: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/44.jpg)
44
References11. Calder PC. Immunonutrition in surgical and critically ill patients. British
Journal of Nutrition [serial online]. 2007;98(Suppl. 1):S133-S139. Available from: PubMed. Accessed January 17, 2014.
12. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enteral Nutr [serial online]. 2009;33:277. Available from: Sage Pub. Accessed January 20, 2014.
13. Braga M, Wischmeyer PE, Drover J, Heyland DK. Clinical evidence for pharmaconutrition in major elective surgery. JPEN J Parenter Enteral Nutr [serial online]. 2013;37:66S. Available from: Sage Pub. Accessed January 20, 2014.
14. Rodera PC, de Luis DA, Gomez Candela C, Culebras JM. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a systematic review. Nutr Hosp [serial online]. 2012;27(3):681-690. Available from: PubMed. Accessed January 18, 2014.
![Page 45: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/45.jpg)
45
References 15. de Luis DA, Izaola O, Cuellar L, Terroba MC, Aller R. Randomized clinical trial
with an enteral arginine-enhanced formula in early postsurgical head and neck cancer patients. Eur J Clin Nutr [serial online]. 2004;58:1505-1508. Available from: PubMed. Accessed January 17, 2014.
16. de Luis DA, Aller R, Izaola O, Cuellar L, Terroba MC. Postsurgery enteral nutrition in head and neck cancer patients. Eur J Clin Nutr [serial online]. 2002;56:1126-1129. Available from: PubMed. Accessed January 17, 2014.
17. Riso S, Aluffi P, Brugnan M, Farinetti F, Pia F, D’Andrea F. Postoperative enteral immunonutrition in head and neck cancer patients. Clin Nutr [serial online]. 2000;19(6):407-412. Available from: PubMed. Accessed Janurary 17, 2014.
18. van Bokhorst-de van der Schueren MAE, Quak JJ, von Blomberg-van der Flier BME, et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severaly malnourished head and neck cancer patients. Am J Clin Nutr [serial online]. 2001;73:323-332. Available from: PubMed. Accessed January 17, 2014.
19. The Evidence Analysis Library. ADA Oncology Evidence-based Nutrition Practice Guideline page. Available at: http://andevidencelibrary.com/topic.cfm?cat=3250. Accessed January 17, 2014.
20. Abbott Laboratories Inc. 2012 Abbott Nutrition Pocket Guide. Concord, NH: Litho in USA; 2011.
![Page 46: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/46.jpg)
46
Thank you!
![Page 47: January 28, 2014 Presented by Natalie Frison,](https://reader036.vdocuments.us/reader036/viewer/2022081513/56815f4a550346895dce2641/html5/thumbnails/47.jpg)
47
Free-Flap Reconstruction: Video Free Fibula for Mandible Reconstruction
by Prof Rida Franka http://www.youtube.com/watch?v=apvie
kOUMng